These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 35276381)

  • 1. Adverse events following COVID-19 vaccination in South Korea between February 28 and August 21, 2021: A nationwide observational study.
    Lee DS; Kim JW; Lee KL; Jung YJ; Kang HW
    Int J Infect Dis; 2022 May; 118():173-182. PubMed ID: 35276381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 Vaccine-Associated Uveitis in Patients With a History of Uveitis.
    Kim J; Kwon HY; Ahn SJ
    JAMA Ophthalmol; 2024 Jun; 142(6):522-528. PubMed ID: 38662361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vertigo and Dizziness After Coronavirus Disease-2019 Vaccination: A Nationwide Analysis.
    Kim SH; Yon DK; Choi YS; Lee J; Park KH; Lee YJ; Park DC; Kim SS; Rim HS; Yeo SG
    J Int Adv Otol; 2023 Jun; 19(3):228-233. PubMed ID: 37272641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Vaccine-Associated Pneumonitis in the Republic of Korea: A Nationwide Multicenter Survey.
    Yoo H; Kim SY; Park MS; Jeong SH; Park SW; Lee HL; Lee HK; Yang SH; Jegal Y; Yoo JW; Lee J; Kang HK; Choi SM; Park J; Kim YW; Song JW; Park JH; Choi WI; Choi HS; Park C; Park JW; Chung MP
    J Korean Med Sci; 2023 Apr; 38(14):e106. PubMed ID: 37038643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of encephalitis and meningitis after COVID-19 vaccination in South Korea: a self-controlled case series analysis.
    Kim JH; Yoon D; Ko HY; Jung K; Sunwoo JS; Shin WC; Byun JI; Shin JY
    BMC Med; 2024 Mar; 22(1):123. PubMed ID: 38486297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents.
    Karlstad Ø; Hovi P; Husby A; Härkänen T; Selmer RM; Pihlström N; Hansen JV; Nohynek H; Gunnes N; Sundström A; Wohlfahrt J; Nieminen TA; Grünewald M; Gulseth HL; Hviid A; Ljung R
    JAMA Cardiol; 2022 Jun; 7(6):600-612. PubMed ID: 35442390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between history of SARS-CoV-2 infection and severe systemic adverse events after mRNA COVID-19 vaccination among U.S. adults.
    Tompkins LK; Baggs J; Myers TR; Gee JM; Marquez PL; Kennedy SB; Peake D; Dua D; Hause AM; Strid P; Abara W; Rossetti R; Shimabukuro TT; Shay DK
    Vaccine; 2022 Dec; 40(52):7653-7659. PubMed ID: 36372665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature.
    Jarius S; Bieber N; Haas J; Wildemann B
    J Neurol; 2022 Oct; 269(10):5198-5212. PubMed ID: 35737110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse Events in Healthcare Workers after the First Dose of ChAdOx1 nCoV-19 or BNT162b2 mRNA COVID-19 Vaccination: a Single Center Experience.
    Kim SH; Wi YM; Yun SY; Ryu JS; Shin JM; Lee EH; Seo KH; Lee SH; Peck KR
    J Korean Med Sci; 2021 Apr; 36(14):e107. PubMed ID: 33847085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of COVID-19 vaccination in patients with previous cerebral venous sinus thrombosis.
    Gil-Díaz A; Gil-Hernández A; Lozano-Jiménez AI; Benítez-Peña J; Conde-Martel A
    Thromb Res; 2022 Jan; 209():84-85. PubMed ID: 34896915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 in South Korea: Proper Timing for Easing Mask Mandates After COVID-19 Vaccination.
    Kang YJ
    Disaster Med Public Health Prep; 2022 Oct; 16(5):1832-1834. PubMed ID: 34346306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seizures following COVID-19 vaccination in Mexico: A nationwide observational study.
    Núñez I; García-Grimshaw M; Castillo Valencia CY; Aguilera Callejas DE; Moya Alfaro ML; Saniger-Alba MDM; Gutiérrez-Romero A; Carrillo-Mezo R; Ceballos-Liceaga SE; Baptista-Rosas RC; López-Gatell H; Reyes-Terán G; Díaz-Ortega JL; Arauz A; Valdés-Ferrer SI; Hernández-Vanegas LE
    Epilepsia; 2022 Oct; 63(10):e144-e149. PubMed ID: 35943891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases.
    Català A; Muñoz-Santos C; Galván-Casas C; Roncero Riesco M; Revilla Nebreda D; Solá-Truyols A; Giavedoni P; Llamas-Velasco M; González-Cruz C; Cubiró X; Ruíz-Villaverde R; Gómez-Armayones S; Gil Mateo MP; Pesqué D; Marcantonio O; Fernández-Nieto D; Romaní J; Iglesias Pena N; Carnero Gonzalez L; Tercedor-Sanchez J; Carretero G; Masat-Ticó T; Rodríguez-Jiménez P; Gimenez-Arnau AM; Utrera-Busquets M; Vargas Laguna E; Angulo Menéndez AG; San Juan Lasser E; Iglesias-Sancho M; Alonso Naranjo L; Hiltun I; Cutillas Marco E; Polimon Olabarrieta I; Marinero Escobedo S; García-Navarro X; Calderón Gutiérrez MJ; Baeza-Hernández G; Bou Camps L; Toledo-Pastrana T; Guilabert A
    Br J Dermatol; 2022 Jan; 186(1):142-152. PubMed ID: 34254291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial.
    Madhavan M; Ritchie AJ; Aboagye J; Jenkin D; Provstgaad-Morys S; Tarbet I; Woods D; Davies S; Baker M; Platt A; Flaxman A; Smith H; Belij-Rammerstorfer S; Wilkins D; Kelly EJ; Villafana T; Green JA; Poulton I; Lambe T; Hill AVS; Ewer KJ; Douglas AD
    EBioMedicine; 2022 Nov; 85():104298. PubMed ID: 36229342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of digestive symptoms after COVID-19 vaccination: A retrospective single-center study.
    Lee DS; Kim JW; Lee KL; Jung YJ; Kang HW
    Am J Emerg Med; 2022 Aug; 58():154-158. PubMed ID: 35691237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of AZD1222 and BNT162b2 COVID-19 Vaccination With Thromboembolic and Thrombocytopenic Events in Frontline Personnel : A Retrospective Cohort Study.
    Hviid A; Hansen JV; Thiesson EM; Wohlfahrt J
    Ann Intern Med; 2022 Apr; 175(4):541-546. PubMed ID: 35103482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk for Myocardial Infarction, Stroke, and Pulmonary Embolism Following COVID-19 Vaccines in Adults Younger Than 75 Years in France.
    Botton J; Jabagi MJ; Bertrand M; Baricault B; Drouin J; Le Vu S; Weill A; Farrington P; Zureik M; Dray-Spira R
    Ann Intern Med; 2022 Sep; 175(9):1250-1257. PubMed ID: 35994748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance.
    Ruggiero R; Balzano N; Di Napoli R; Mascolo A; Berrino PM; Rafaniello C; Sportiello L; Rossi F; Capuano A
    Front Immunol; 2022; 13():956825. PubMed ID: 36177033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 vaccination in people with multiple sclerosis, real-life experience.
    Alroughani R; Al-Hashel J; Abokalawa F; AlMojel M; Farouk Ahmed S
    Clin Neurol Neurosurg; 2022 Sep; 220():107374. PubMed ID: 35961255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.